Attenuation of rotenone-induced neurodegeneration by Bacillus coagulans supplementation in zebrafish
- Monalisa Rout 1, Shakti Ketan Prusty 1, Sonali Sahoo 1, Prerana Sarangi 2, Anshuman Rath 1, Durga Madhab Kar 1
- 1School of Pharmaceutical Sciences, Siksha 'O' Anusandhan deemed to be University, Bhubaneswar, India.
- 2Centre for Biotechnology, Siksha 'O' Anusandhan deemed to be University, Bhubaneswar, India.
- 0School of Pharmaceutical Sciences, Siksha 'O' Anusandhan deemed to be University, Bhubaneswar, India.
|
October 16, 2025
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Bacillus coagulans (PBT) probiotic supplementation shows promise in mitigating Parkinson's disease (PD) symptoms and neurodegeneration in a zebrafish model. PBT, alone or with L-dopa, rescued rotenone-induced behavioral and biochemical deficits.
Area Of Science
- Neuroscience
- Microbiology
- Pharmacology
Background
- Parkinson's disease (PD) is a progressive neurodegenerative disorder.
- Current treatments for PD have limitations.
- Bacillus coagulans (PBT) possesses potential therapeutic properties.
- The anti-PD effects of PBT have not been studied in a zebrafish model.
Purpose Of The Study
- To investigate the anti-Parkinson's disease (PD) activity of Bacillus coagulans (PBT) in a rotenone-induced zebrafish model.
- To evaluate the impact of PBT on neurobehavioral changes, neuroinflammation, and neurodegeneration associated with PD.
Main Methods
- A 28-day study using zebrafish exposed to rotenone (ROT) to induce PD-like symptoms.
- Treatment groups included control, ROT, ROT + L-dopa, ROT + PBT, PBT + L-dopa, and PBT.
- Behavioral tests (novel tank test, light-dark test) were conducted.
- Biomarkers including dopamine, alpha-synuclein, MAO-B, AChE, and nitrite were measured.
- Brain histology was performed to assess neuronal damage.
Main Results
- PBT, alone and with L-dopa, significantly attenuated rotenone-induced behavioral deficits.
- PBT treatment restored altered antioxidant biomarker activity and dopamine levels.
- PBT administration reduced aggregated alpha-synuclein levels and MAO-B activity.
- Brain histology revealed PBT prevented rotenone-induced neuronal damage.
Conclusions
- Chronic rotenone exposure induces neurobehavioral changes, neuroinflammation, and neurodegeneration in zebrafish.
- Bacillus coagulans (PBT) supplementation effectively rescued these rotenone-induced effects.
- PBT demonstrates potential as a therapeutic agent for Parkinson's disease, warranting further clinical investigation.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

